Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Fanconi Anemia Pathway Inhibits mTOR Signaling and Prevents Accelerated Translation in Head and Neck Cancer Cells

Cancers(2025)10.3390/cancers17152583Source: DataRank Database

The Fanconi Anemia Pathway Inhibits mTOR Signaling and Prevents Accelerated Translation in Head and Neck Cancer Cells is a research paper published in Cancers (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

gen uniprot doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.41)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Sara Vicente-Muñoz ORCID,Khyati Y. Mehta ORCID,Cosette M. Rivera‐Cruz ORCID,Xueheng Zhao ORCID,Lindsey E. Romick‐Rosendale ORCID

Live enrichment

PubMed:40805278 PMC:PMC12346401 OpenAlex:https://openalex.org/W4413023914

National Cancer Institute (NCI) within the National Institutes of Health (NIH)

Grant: F30 CA281167

National Cancer Institute (NCI) within the National Institutes of Health (NIH)

Grant: R01 CA223790

National Cancer Institute (NCI) within the National Institutes of Health (NIH)

Grant: F31 DK131885

National Cancer Institute (NCI) within the National Institutes of Health (NIH)

Grant: T32 ES007250

NIH HHS

Grant: 5R01CA223790-05

NIH HHS

Grant: 1F30CA281167-01A1

NIH HHS

Grant: 5T32ES007250-34

NIH HHS

Grant: 1F31DK131885-01A1

FWCI

0.41

Citation Percentile

0.6%

Citation Trend

2026

goldLicense: cc-by

journalhttps://doi.org/10.3390/cancers17152583

publisherhttps://doi.org/10.3390/cancers17152583

publisherhttps://www.mdpi.com/2072-6694/17/15/2583/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40805278

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12346401

Fields of Study

CRISPR and Genetic EngineeringPI3K/AKT/mTOR signaling in cancerPolyamine Metabolism and ApplicationsMedicineBiology

Keywords

PI3K/AKT/mTOR pathwayHead and neck squamous-cell carcinomaRPTORCancer researchFanconi anemiaMechanistic target of rapamycinGenome instabilityBiologyRibosomal protein s6SirolimusDNA repairCell growthCell biologyP70-S6 Kinase 1DNA damageSignal transductionCancerBiochemistryGeneDNAGeneticsHead and neck cancerMtorCancer Metabolism

Sustainable Development Goals

SDG 0: Good health and well-being

The Fanconi Anemia Pathway Inhibits mTOR Signaling and Prevents Accelerated Translation in Head and Neck Cancer Cells

FAIR Checklist

Authors (9)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)